Back
SNDL 10K Form
Sell
40
SNDL
SNDL
Last Price:
2.34
Seasonality Move:
70.9%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SNDL News And Ratings
See the #1 stock for the next 7 days that we like better than SNDL
SNDL Financial Statistics
Sales & Book Value
| Annual Sales: | $673.21M |
|---|---|
| Cash Flow: | $2.6M |
| Price / Cash Flow: | 18.96 |
| Annual Sales: | $3.39 |
| Price / Book: | 0.64 |
Profitability
| EPS (TTM): | -0.31670 |
|---|---|
| Net Income (TTM): | $-83.16M |
| Gross Margin: | $141.02M |
| Return on Equity: | -8.8% |
| Return on Assets: | -7.41% |
SNDL Earnings Forecast
Key SNDL Financial Ratios
- The Gross Profit Margin over the past 6 years for SNDL is 20.95%.
- The Selling, General & Administrative Expenses for SNDL have been equal to 25.32% of Gross Profit Margin.
- The Research & Development expenses have been 0.04% of Revenue.
- The Interest Expense is -4.59% of Operating Income.
- The Net Earning history of SNDL is -18.99% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 3 years.
SNDL Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SNDL |
| CUSIP: | 86730L |
| Website: | sndl.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.34 |
| Quick Ratio: | 2.39 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 37.48 |